Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Sci Rep ; 7(1): 10714, 2017 09 06.
Artículo en Inglés | MEDLINE | ID: mdl-28878369

RESUMEN

Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor that is deregulated in obesity. PPARγ exerts diverse antineoplastic effects. Attempting to determine the clinical relevance of the epigenetic mechanisms controlling the expression PPARγ and susceptibility to colorectal cancer (CRC) in obese subjects, this study investigated the role of some microRNAs and DNA methylation on the deregulation of PPARγ. Seventy CRC patients (34 obese and 36 lean), 22 obese and 24 lean healthy controls were included. MicroRNA levels were measured in serum. PPARγ promoter methylation was evaluated in peripheral blood mononuclear cells (PBMC). PPARγ level was evaluated by measuring mRNA level in PBMC and protein level in serum. The tested microRNAs (miR-27b, 130b and 138) were significantly upregulated in obese and CRC patients. Obese and CRC patients had significantly low levels of PPARγ. A significant negative correlation was found between PPARγ levels and the studied microRNAs. There was a significant PPARγ promoter hypermethylation in CRC patients that correlated to low PPARγ levels. Our results suggest that upregulation of microRNAs 27b, 130b and 138 is associated with susceptibility to CRC in obese subjects through PPARγ downregulation. Hypermethylation of PPARγ gene promoter is associated with CRC through suppression of PPARγ regardless of BMI.


Asunto(s)
Neoplasias Colorrectales/genética , Epigénesis Genética , Regulación de la Expresión Génica , Obesidad/genética , PPAR gamma/genética , Estudios de Casos y Controles , MicroARN Circulante , Neoplasias Colorrectales/sangre , Neoplasias Colorrectales/metabolismo , Metilación de ADN , Humanos , MicroARNs/sangre , MicroARNs/genética , Obesidad/sangre , Obesidad/metabolismo , PPAR gamma/sangre , PPAR gamma/metabolismo , Regiones Promotoras Genéticas
2.
J Physiol Biochem ; 70(1): 225-37, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24264056

RESUMEN

This study was designed to assess the effect of naringenin (NRG) on simvastatin (SV)-induced hepatic damage in rat and to investigate the effects of these drugs on cytochrome P450 (CYP) 2E1 and 3A1/2 isoforms in order to evaluate the possibility of their coadministration. Hepatic damage in rat was induced by SV (20 and 40 mg/kg/day, po for 30 days). The protective effect of NRG (50 mg/kg/day, po) was identified by estimating liver functions and oxidative stress markers such as lipid peroxidation, reduced glutathione, superoxide dismutase, glutathion s-transferase, and catalase as well as protein profile. DNA fragmentation and histopathological study were carried out to confirm the hepatic damage. An in vitro study was conducted to further evaluate the effect of SV and/or NRG administration on the activities of two microsomal CYP isoenzymes including CYP2E1 and CYP3A1/2. SV exerted an oxidative stress which may contribute to the hepatotoxicity. Administration of NRG in combination with SV significantly improved the liver functions, state of oxidative stress, protein profile, DNA fragmentation, and the histopathological changes. SV and/or NRG have a potential to inhibit CYP3A1/2 and CYP2E1. This study concluded that concurrent administration of NRG with SV provided a protection of liver tissue against the SV-induced hepatic damage. The inhibition of CYP2E1 and CYP3A1/2 by the SV and NRG should be taken into account in order to adjust doses to avoid interaction between SV and NRG and adverse effects of SV.


Asunto(s)
Anticolesterolemiantes/toxicidad , Antioxidantes/uso terapéutico , Enfermedad Hepática Inducida por Sustancias y Drogas/tratamiento farmacológico , Fragmentación del ADN , Flavanonas/uso terapéutico , Hígado/enzimología , Simvastatina/toxicidad , Alanina Transaminasa/sangre , Animales , Antioxidantes/farmacología , Aspartato Aminotransferasas/sangre , Enfermedad Hepática Inducida por Sustancias y Drogas/sangre , Enfermedad Hepática Inducida por Sustancias y Drogas/enzimología , Citocromo P-450 CYP2E1/metabolismo , Citocromo P-450 CYP3A/metabolismo , Evaluación Preclínica de Medicamentos , Interacciones Farmacológicas , Femenino , Flavanonas/farmacología , Glutatión/metabolismo , Hígado/efectos de los fármacos , Hígado/patología , Malondialdehído/metabolismo , Microsomas Hepáticos/enzimología , Ratas , Ratas Wistar , Superóxido Dismutasa/sangre
3.
Int J Biochem Cell Biol ; 33(5): 475-82, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11331202

RESUMEN

The major goal of this study was to examine the ability of several antioxidants namely, vitamin E, beta-carotene and N-acetylcysteine, to protect the brain from oxidative stress induced by lipopolysaccharide (LPS, endotoxin). LPS, a component of the bacterial wall of gram-negative bacteria, has been recognized as one of the most potent bacterial products in the induction of host inflammatory responses and tissue injury and was used in this study to mimic infections. LPS injection resulted in a significant increase in the stress indices, plasma corticosterone and glucose concentration, a significant alteration of the brain oxidative status observed as elevation of the level of malondialdehyde (MDA, index of lipid peroxidation) and reduction of reduced glutathione (GSH), and a disturbance in the brain energy metabolism presented as a reduction in the ATP/ADP ratio and an increase in the mitochondrial/cytosolic hexokinase ratio. However, the activities of brain superoxide dismutase and Na+, K+-ATPase and contents of cholesterol and phospholipids were not altered. Administration of the aforementioned antioxidants prior to LPS injection ameliorated the oxidative stress by reducing levels of MDA, restoring GSH content and normalizing the mitochondrial/cytosolic hexokinase ratio in the brain in addition to lowering levels of plasma corticosterone and glucose. In conclusion, this study showed the increased free radical generation during infections and LPS-induced stress. It also suggests that brain oxidative status and energy is disturbed.


Asunto(s)
Acetilcisteína/farmacología , Encéfalo/metabolismo , Lipopolisacáridos/farmacología , Estrés Oxidativo , Vitamina E/farmacología , beta Caroteno/farmacología , Adenosina Trifosfato/metabolismo , Animales , Antiinflamatorios/sangre , Antioxidantes/farmacología , Glucemia/metabolismo , Encéfalo/efectos de los fármacos , Colesterol/metabolismo , Corticosterona/sangre , Depuradores de Radicales Libres/farmacología , Glutatión/metabolismo , Hexoquinasa/metabolismo , Lipopolisacáridos/administración & dosificación , Masculino , Malondialdehído/metabolismo , Fosfolípidos/metabolismo , Ratas , Ratas Wistar , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Superóxido Dismutasa/metabolismo
4.
Planta Med ; 60(3): 244-7, 1994 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-8073092

RESUMEN

Zizyphus is one of the plants commonly used in Egyptian folk medicine for the treatment of different diseases. The present study aims to investigate the effect of the butanol extract of Zizyphus spina-christi leaves as well as christinin-A, its principle saponin glycoside, in normal and streptozotocin-diabetic rats. In normal rats, treatment in both cases for one and four weeks produced insignificant changes in all studied parameters. However, in diabetic rats, both treatments significantly reduced serum glucose level, liver phosphorylase and glucose-6-phosphatase (G-6-pase) activities, and significantly increased serum pyruvate level and liver glycogen content after 4 weeks treatment. There was also marked improvement in glucose utilization in diabetic rats in both cases. Serum insulin and pancreatic cAMP levels showed significant increases in diabetic rats treated for a period of 4 weeks with the butanol extract.


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Hipoglucemiantes/uso terapéutico , Extractos Vegetales/uso terapéutico , Plantas Medicinales , Animales , Masculino , Medicina Tradicional , Ratas
5.
Pharmacol Res ; 26(4): 357-66, 1992 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-1284171

RESUMEN

Two phases of arthritis, acute phase (four days after adjuvant inoculation) and chronic phase (21 or 29 days after adjuvant inoculation) were studied in male rats. The effect of administration of vitamin C in a daily oral dose of 50 mg/kg body wt for four and 21 days starting on the day of adjuvant inoculation and for 7 days starting 21 days after adjuvant inoculation against these phases of arthritis was demonstrated. Results showed that prolonged administration of vitamin C (21 days) increased the lowered serum sulphydryl (SH-groups) to prearthritic values while it decreased the elevated level of blood glutathione (GSH) of arthritic rats. However, neither (four-day) nor seven-day treatment with vitamin C exerted any significant changes in these parameters. The results showed also a slight significant increase in the level of erythrocyte superoxide dismutase activity (SOD) [1.15.1.1] upon seven-day treatment with vitamin C. Meanwhile, four-, 21- or seven-day treatment with vitamin C produced no significant change in the elevated levels of serum ceruloplasmin (Cp) and alpha 2-macroglobulin (alpha 2-M) of arthritic rats. However, 21-day and 7-day administration of vitamin C has improved the lowered A/G ratio in these animals. The improvement in these parameters after prolonged administration of vitamin C was explained in the light of the antioxidant property of this vitamin and suggests a beneficial role for it in the treatment of arthritis.


Asunto(s)
Artritis Experimental/metabolismo , Ácido Ascórbico/farmacología , Animales , Biomarcadores , Proteínas Sanguíneas/metabolismo , Ceruloplasmina/metabolismo , Eritrocitos/enzimología , Glutatión/sangre , Masculino , Ratas , Ratas Wistar , Compuestos de Sulfhidrilo/sangre , Superóxido Dismutasa/sangre , alfa-Macroglobulinas/metabolismo
6.
Agents Actions ; 36(3-4): 300-5, 1992 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-1382381

RESUMEN

Two phases of adjuvant arthritis, acute phase (4 days after adjuvant inoculation) and chronic phase (21 and 29 days after adjuvant inoculation) were studied in male rats. The effect of administration of vitamin E in a daily oral dose of 147 mg/kg body wt. for one week against these phases of arthritis were demonstrated before and after adjuvant inoculation. Results showed that administration of the vitamin before and after adjuvant inoculation increased the lowered serum-SH group in arthritic rats so that their level was restored to pre-arthritic values especially in chronic treated group. Meanwhile, these treatments produced no change in the increased level of blood GSH or erythrocyte SOD activity of arthritic rats. The results showed also that administration of vitamin E before adjuvant inoculation increased significantly the level of alpha 2-M while it did not alter the increased serum Cp in acute phase. However, administration of the vitamin after adjuvant inoculation failed to exert any change in these parameters. In the meantime, these treatments tended to increase the lowered A/G of arthritic rats in different phases especially in acute one. These observations suggest that antioxidants such as vitamin E may be beneficial for arthritis.


Asunto(s)
Artritis Experimental/metabolismo , Vitamina E/farmacología , Animales , Ceruloplasmina/metabolismo , Eritrocitos/enzimología , Glutatión/sangre , Masculino , Ratas , Ratas Endogámicas , Superóxido Dismutasa/sangre , alfa-Macroglobulinas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA